Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39037

DNAAF5 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The DNAAF5 Knockout Raji Polyclonal Cells are CRISPR/Cas9-edited polyclonal Raji B lymphocytes with disruption of DNAAF5, a co-chaperone for axonemal dynein assembly. DNAAF5 interacts with DNAAF1, DNAAF2, and dynein chains, functioning downstream of FOXJ1. Its mutation causes primary ciliary dyskinesia, but non-ciliary roles are unexplored. This knockout pool facilitates study of DNAAF5 in B-cell biology, including cell cycle and apoptosis assays, protein interaction analysis, and drug sensitivity testing. The polyclonal nature reduces clonal artifacts. Contact Ascent Research for more information.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DNAAF5

    Gene Identifier

    NCBI Gene ID 54919

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAAF5 Knockout Raji Polyclonal Cells product consists of a population of Raji B lymphocytes subjected to CRISPR/Cas9-mediated disruption of the DNAAF5 gene, resulting in a heterogeneous polyclonal knockout pool. This format eliminates the need for time-consuming clonal isolation and provides a robust, population-level loss-of-function model. The polyclonal nature reduces the impact of any single off-target event and is well-suited for experiments requiring large cell numbers, such as biochemical assays or high-throughput screens.

The Raji parental cell line is an Epstein-Barr virus (EBV)-positive B lymphocyte line established from a Burkitt??s lymphoma patient. It has been a cornerstone in immunological and cancer research for decades, offering a reliable suspension culture system that recapitulates features of B-cell malignancies. Raji cells are amenable to electroporation and other delivery methods, enabling efficient CRISPR/Cas9 gene editing and subsequent functional analyses, including flow cytometry, co-immunoprecipitation, and protein interaction studies.

DNAAF5 encodes a cytoplasmic co-chaperone essential for the preassembly of axonemal dynein complexes, the multi-subunit motors required for ciliary and flagellar movement. This protein functions downstream of the master transcription factors FOXJ1 and RFX3, which orchestrate ciliary gene expression. DNAAF5 physically associates with other dynein assembly factors, specifically DNAAF1, DNAAF2, and DNAAF3, as well as with dynein intermediate chains DNAI1 and DNAI2, facilitating the proper folding and incorporation of heavy chains such as DNAH5 and DNAH11 into the axonemal dynein complex. Mutations in DNAAF5 lead to defective dynein arm assembly, immotile cilia, and clinical manifestations of primary ciliary dyskinesia, including Kartagener syndrome. Although Raji B lymphocytes are non-ciliated, the expression of DNAAF5 suggests potential extra-ciliary functions that remain to be elucidated, making the knockout model a valuable tool for discovery.

In the Raji B-cell context, disruption of DNAAF5 allows researchers to probe its non-canonical roles in lymphocyte biology and lymphoma pathogenesis. Because the protein??s chaperone activity may extend to non-dynein clients, knockout cells could reveal impacts on protein folding, cell cycle progression, or apoptosis. This model is particularly relevant for investigating how genes traditionally linked to ciliopathies may contribute to hematological malignancy and immune dysregulation, thereby expanding their functional repertoire beyond motile cilia.

This polyclonal knockout pool supports various applications: Western blotting and RT-qPCR for confirming gene disruption, flow cytometry for cell cycle and apoptosis analysis, and co-immunoprecipitation to probe dynein assembly factor interactions. It is also suitable for functional genomics screens and drug response studies. For additional product information or a quote, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)